46 results
6-K
EX-99.5
SOPH
SOPHiA Genetics SA
5 Mar 24
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
7:00am
of the research and development department. The lease in total is for approximately 38,750 square feet with the Company gaining access to areas
6-K
EX-99.1
SOPH
SOPHiA Genetics SA
5 Mar 24
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
7:00am
of capitalized research & development expenses that are necessary for such reconciliation. In addition, the Company does not provide a reconciliation of forward … in forecasting and quantifying amortization of capitalized research & development expenses and intangible assets, share-based compensation expenses
6-K
EX-99.3
SOPH
SOPHiA Genetics SA
5 Mar 24
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
7:00am
thousands, except per share data)
Year ended December 31,
Notes
Revenue
Cost of revenue
Gross profit
Research and development costs
Selling … supplies, consulting services, computer costs and data storage fees paid to hosting providers related to research and development and allocated overhead
6-K
EX-99.2
SOPH
SOPHiA Genetics SA
10 Jan 24
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
4:59pm
) Amortization of capitalized research and development expenses consists of software development costs amortized using the straight - line method over … an estimated life of five years . These expenses do not have a cash impact but remain a recurring expense generated over the course of our research
6-K
EX-99.1
8lv69uspfl
7 Nov 23
Index to Consolidated Financial Statements
7:02am
6-K
EX-99.2
tmh0e5uu2jfq7 vfp2f
7 Nov 23
Index to Consolidated Financial Statements
7:02am
6-K
EX-99.3
vyv 4s71z
7 Nov 23
Index to Consolidated Financial Statements
7:02am
6-K
EX-99.1
rsnqm7i7mdepm gzi
14 Aug 23
Current report (foreign)
8:41am
424B5
kg4iwf
8 Aug 23
Prospectus supplement for primary offering
5:04pm
6-K
EX-99.1
876u16cug
8 Aug 23
Index to Consolidated Financial Statements
7:14am
6-K
EX-99.3
yp5qa9ysiwpx e82
8 Aug 23
Index to Consolidated Financial Statements
7:14am
6-K
EX-99.2
ptpr0gzvgu29nf 1cemt
8 Aug 23
Index to Consolidated Financial Statements
7:14am
6-K
EX-99.1
rtsj 57lxn1dxr3b69t
6 Jun 23
Current report (foreign)
6:00am
6-K
EX-99.1
vbml2rq2
17 May 23
Invitation to the Annual General Meeting
6:01am
6-K
EX-99.1
kn9j bdo72qzg7s
12 May 23
Current report (foreign)
6:05am
6-K
EX-99.1
ltv2gmp9484 bfdpk
9 May 23
Index to Consolidated Financial Statements
7:08am
6-K
EX-99.3
bjlgd7u fdrtr
9 May 23
Index to Consolidated Financial Statements
7:08am
6-K
EX-99.2
w12my76cq1ohtgrkb
9 May 23
Index to Consolidated Financial Statements
7:08am
6-K
EX-99.1
rosmpg uk
8 Nov 22
Index to Consolidated Financial Statements
7:00am